| Literature DB >> 35322881 |
Shaikhah Alsamahi1, Trudy M Milne1, Haizal Hussaini1, Alison M Rich1, Lara T Friedlander1.
Abstract
AIM: The aim of this study was to investigate the effect of type 2 diabetes (T2D) on clinically normal dental pulp tissue by using special stains and immunohistochemistry (IHC) to determine the morphology of the coronal pulp and distribution of immune markers in non-T2D and T2D groups.Entities:
Keywords: dental pulp; histomorphology; immune response; immunohistochemistry; type 2 diabetes
Mesh:
Substances:
Year: 2022 PMID: 35322881 PMCID: PMC9324782 DOI: 10.1111/iej.13732
Source DB: PubMed Journal: Int Endod J ISSN: 0143-2885 Impact factor: 5.165
FIGURE 1Histological images of coronal clinically normal dental pulp from non‐T2D and T2D participants (H&E staining); (a), (c), and (e) representative non‐T2D dental pulp and (b), (d), (f), (g) and (h) representative TR2D dental pulp. The T2D dental pulp shows denser collagen with a notable presence of tertiary dentine. It appears less cellular, has thickened blood vessel walls, and the presence of amorphous calcified stones within the T2D pulp tissue was common. (a and b; 2× magnification, scale bar, 1 mm, (c),(d), (g) and (h); 20× magnification, 100 μm, e and f; 40× scale bar 50 μm). D, dentine; PD, predentine; O, odontoblast; P, central pulp; CFZ, cell free zone; CRZ, cell rich zone; BV, blood vessels; TD, tertiary dentine; S, pulp calcification/stone
FIGURE 2Special stain images showing the histomorphology of the clinically normal dental pulp from non‐T2D and T2D participants; (a) and (c) representative non‐T2D dental pulp and (b) and (d) representative T2D dental pulp; (a) and (b) shows Masson's trichrome stain; the intensity of blue collagen stain in central region of dental pulp and around thickened blood vessels (black arrows) was increased in T2D group. Endothelial cells lining blood vessels are stained black; (c) and (d) shows Van Gieson stain; collagen staining was intense in T2D dental pulp especially around blood vessels compared with the non‐T2D dental pulp. The presence of neurovascular bundles was less evident in T2D samples. (a–d; 40× scale bar 50 µm). BV, blood vessels; EC, endothelial cells; NVB, neurovascular bundle
FIGURE 3Line plot graph showing the mean total non‐endothelial cell nuclei and blood vessel count/section in T2D and non‐T2D dental pulp samples using an unpaired Student's t‐test (*p‐value .05). The error bar indicates standard deviation
Mean number and standard deviation (SD) of immunopositive cells for antibody markers of immune cells and cytokines in T2D and non‐T2D samples
| Antibodies | Non‐T2D | T2D |
| ||
|---|---|---|---|---|---|
| Mean | SD | Mean | SD | ||
| Anti‐CD4 | 120.40 | 45.45 | 137.30 | 36.17 | .37 |
| Anti‐CD68 | 74.80 | 28.09 | 144.00 | 41.74 | <.001 |
| Anti‐CD83 | 59.30 | 31.49 | 85.40 | 21.67 | .04 |
| Anti‐IL1β | 80.70 | 38.55 | 121.00 | 23.45 | .01 |
| Anti‐IL6 | 139.50 | 27.79 | 236.40 | 42.84 | <.0001 |
| Anti‐IL17 | 52.90 | 17.78 | 115.20 | 19.10 | <.0001 |
| Anti‐TNF‐α | 97.00 | 18.69 | 124.6 | 24.84 | .01 |
| Anti‐FOXP3 | 164.30 | 42.96 | 122.50 | 21.70 | .01 |
| Anti‐TLR2 | 28.00 | 9.17 | 64.10 | 21.65 | <.001 |
| Anti‐TLR4 | 26.00 | 13.20 | 53.30 | 12.23 | <.001 |
Summary of multiple regression model analysis for quantitative assessment
| Antibodies outcome variable |
| df |
|
|
|---|---|---|---|---|
| Anti‐CD4 | .31 | 2 | 3.90 | .04 |
| Anti‐CD68 | .58 | 2 | 11.66 | <.001 |
| Anti‐CD83 | .56 | 2 | 10.65 | <.001 |
| Anti‐IL1β | .55 | 2 | 10.37 | .01 |
| Anti‐IL6 | .92 | 2 | 108.0 | <.001 |
| Anti‐IL17 | .80 | 2 | 34.31 | <.001 |
| Anti‐TNF‐α | .68 | 2 | 7.47 | .01 |
| Anti‐FOXP3 | .41 | 2 | 5.80 | .01 |
| Anti‐TLR2 | .77 | 2 | 28.6 | <.001 |
| Anti‐TLR4 | .64 | 2 | 16.34 | <.001 |
Predictor (constant) T2D status, Age.
Correlation of the relationship between the expression of inflammatory markers with diabetes status and age
| Antibodies | Diabetes status | Age | ||
|---|---|---|---|---|
|
|
|
|
| |
| Anti‐CD4 | −22.12 | .02* | −1.6 | .08 |
| Anti‐CD68 | −68.93 | <.001*** | −1.25 | .42 |
| Anti‐CD83 | −28.97 | .01** | .22 | .77 |
| Anti‐IL1β | −43.51 | <.001*** | −.85 | .42 |
| Anti‐IL6 | −98.24 | <.001*** | −.36 | .63 |
| Anti‐IL17 | −65.00 | .01** | −1.21 | .16 |
| Anti‐TNF‐α | −28.78 | .002** | −.31 | .71 |
| Anti‐FOXP3 | 42.63 | .01** | .22 | .88 |
| Anti‐TLR2 | −36.78 | <.001*** | −.18 | .74 |
| Anti‐TLR4 | −24.92 | <.001*** | .63 | .27 |
*p ≤ .05;
**p ≤ .01;
***p ≤ .001
FIGURE 4Photomicrograph showing immunolabelling pattern of anti‐TLR2, anti‐TLR4 and anti‐FOXP3 from non‐T2D and T2D participants, and positive and negative control samples. Anti‐TLR2 staining was only very weakly detected in the odontoblast region (a and b) while moderate anti‐TLR4 staining was found (e and f). Strong anti‐FOXP3 staining was observed for non‐T2D samples around blood vessels (i) while in the T2D samples staining was weak (j). Black arrows indicate positive staining. Lymph node tissue was used as the positive control for all antibodies and non‐specific monoclonal IgG was used as a negative control (a–l; 40× magnification, scale bar 50 µm)